Grepafloxacin
Paul G. Auwaerter, M.D.
,
Edina Avdic, Pharm.D.
INDICATIONS
INDICATIONS
INDICATIONS
FDA
FDA
FDA
No longer manufactured for U.S. or global markets due to QTc prolongation; withdrawn in the U.S. in 1999 (due to cardiac events and sudden death)
NON-FDA APPROVED USES
NON-FDA APPROVED USES
NON-FDA APPROVED USES
Acute exacerbation of chronic bronchitis
Chlamydial infection
Community-acquired pneumonia
Gonorrhea
There's more to see -- the rest of this topic is available only to subscribers.
© 2000–2025 Unbound Medicine, Inc. All rights reserved
All content is protected by copyright and may not be used for AI model training or other unauthorized purposes.